Cochlear implant device manufacturers, Starkey and MED-EL, announce partnership to boost Bluetooth connectivity for implant users via DualSync technology.
## Bimodal Streaming Partnership Between Starkey and MED-EL Enhances Access to Advanced Hearing Technology
In a groundbreaking move, Starkey and MED-EL, two industry leaders in the hearing technology sector, have announced a collaboration to introduce DualSync, a bimodal streaming partnership. This partnership reflects a shared commitment to delivering excellence without exception and aims to expand access to the latest hearing technology worldwide [1].
The collaboration is designed to bring advanced hearing technology to a global audience by combining Starkey's industry-leading hearing aids with MED-EL's cochlear implant innovation for a seamless wireless audio experience [2]. The partnership is centered around a commitment to delivering the latest in hearing technology and prioritizes patient-centric solutions in the hearing industry [3].
Starting July 1, 2025, Starkey Edge AI and Genesis AI hearing aids, and MED-EL Sonnet 3, Sonnet 2, Sonnet, and Rondo 3 audio processors will be compatible for bimodal streaming [1][2][3]. This compatibility will enable users who utilize both cochlear implants and hearing aids to enjoy a more natural and connected hearing environment.
DualSync technology is at the heart of this partnership. It provides seamless audio connectivity and synchronized sound from compatible smartphones and media devices, enhancing the user's experience by offering a unified wireless audio connection [1][3][5]. The technology also simplifies the pairing process, as Apple devices recognize both the hearing aid and the cochlear implant as a pair [5].
The solution is designed to support a growing ecosystem of devices and will be compatible with future innovations from both companies [1][2]. This ensures that users will continue to benefit from the latest advancements in hearing technology.
Dr. Ingeborg Hochmair, co-founder and CEO of MED-EL, added that the partnership delivers a global solution for bimodal users, providing effortless connectivity, clearer sound, and greater control in their daily lives [4]. Brandon Sawalich, President and CEO of Starkey, echoed this sentiment, stating that the partnership reflects a shared commitment to delivering excellence without exception [1].
This partnership is a significant step forward in the hearing technology sector, aiming to improve the listening experience for users with both hearing aids and cochlear implants, and connecting more people back to the things they love most. The collaboration between Starkey and MED-EL is focused on enhancing the accessibility and quality of hearing technology, and emphasizes a dedication to innovation in the sector.
- The partnership between Starkey and MED-EL, two leaders in digital health and technology, is set to revolutionize the hearing industry by offering a unified wireless audio connection, delivering patient-centric solutions that prioritize the latest in medical-conditions and health-and-wellness.
- In the realm of femtech news, this collaboration marks a significant stride in the digital health sector, as it aims to provide a global solution for bimodal users, improving their daily lives by offering effortless connectivity and clearer sound.
- The collaboration between Starkey and MED-EL underscores a shared commitment to science and technology, ensuring continuous advancements in hearing technology and a growing ecosystem of compatible devices, ultimately benefiting users worldwide.
